RxDoctor Payments Data

Ciera Rogers

Nurse Practitioner · Salina, KSNPI 1225656192

Payments from drug & device makers

$719in general payments, 2019–2025

Across 36 payments — averaging $19.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Harmony Biosciences LLC$336
  • AstraZeneca$181
  • Sanofi$50
  • Mayne Pharma Commercial LLC$49
  • Grifols USA, LLC$37
  • Amgen$24
  • plus $42 from 3 others

What the payments were for

  • Food & beverage$54175%
  • Education$17825%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$719 in reported general payments places this provider in the 70th percentile of 1,326 nurse practitioner providers in Kansas.

See all nurse practitioner providers in Kansas

Medicare billing

Part B allowed, 2024
$79,730
Medicare patients
736
Services billed
1,019

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter350$245,480
Prolastin CAlpha-1-Proteinase Inhibitor11$120,707
Breztri AerosphereBudesonide/Glycopyr/Formoterol161$108,074
Dupixent PenDupilumab13$50,925
Breo ElliptaFluticasone/Vilanterol39$20,578
DuleraMometasone/Formoterol32$13,824
Combivent RespimatIpratropium/Albuterol Sulfate25$12,447
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$10,123
SymbicortBudesonide/Formoterol Fumarate29$8,523
Albuterol Sulfate HfaAlbuterol Sulfate225$7,527
Fluticasone-SalmeterolFluticasone Propion/Salmeterol35$6,587
Stiolto RespimatTiotropium Br/Olodaterol Hcl14$6,528
Incruse ElliptaUmeclidinium Bromide11$6,154
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate50$5,888
Bevespi AerosphereGlycopyrrolate/Formoterol Fum11$4,446

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta, Arnuity Ellipta$14$285,737433 claims
AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere$181$121,042201 claims
Grifols USA, LLCProlastin C$37$120,70711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,326 nurse practitioner providers in Kansas.

Other nurse practitioner in Salina

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →